UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032366
Receipt number R000036915
Scientific Title Multicenter case registration study of pulmonary hypertension with congenital heart disease
Date of disclosure of the study information 2018/04/25
Last modified on 2021/09/18 09:18:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter case registration study of pulmonary hypertension with congenital heart disease

Acronym

Multicenter case registration study of pulmonary hypertension with congenital heart disease

Scientific Title

Multicenter case registration study of pulmonary hypertension with congenital heart disease

Scientific Title:Acronym

Multicenter case registration study of pulmonary hypertension with congenital heart disease

Region

Japan


Condition

Condition

CHD-PAH (pulmonary arterial hypertension with congenital heart disease)

Classification by specialty

Cardiology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To prove the validity of treatment strategy in Japan and contribute to making the evidence-based guideline for CHD-PAH treatment

Basic objectives2

Others

Basic objectives -Others

To clarify the survival rate of CHD-PAH patients

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Survival rate of CHD-PAH patients

Key secondary outcomes

1. Status of medical treatment in CHD-PAH patients
2. Factors influencing outcome (survival rate)
3. Predictive factors of clinical worsening
4. Relationship between treatment drugs and outcome
5. Validity of treat and repair strategy
6. Similarity and difference of clinical course according to the shunt sites


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Any age
2. PH with any CHD who have no plan to have cardiac surgery or catheter intervention within 6 months
3. The diagnosis of PAH is made by cardiac catheterization. mean PAp>20mmHg or PVRI>=3Woodm2
4. Both cases with repaired or unrepaired shunt lesion
5. Cases with Fontan circulation or complex heart disease with major aortopulmonary collateral arteries included as specific patient groups
6. Cases participating another study

Key exclusion criteria

1. A case planned to have cardiac surgery or catheter intervention within 6 months
2. A case performed cardiac surgery or catheter intervention within 6 months
3. A case with extremely unstable status
4. A case without informed consent
5. A case judged as inappropriate by principal investigator

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Nobuhisa
Middle name
Last name Hagiwara

Organization

Tokyo Women's Medical University

Division name

Department of Cardiology

Zip code

162-8666

Address

Kawada-cho 8-1, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Email

hagiwara.nobuhisa@twmu.ac.jp


Public contact

Name of contact person

1st name Taku
Middle name
Last name Ishii

Organization

Tokyo Medical and Dental University Hospital

Division name

Department of Pediatrics

Zip code

113-8510

Address

Yushima 1-5-45 Bunkyo-ku Tokyo

TEL

03-5803-5249

Homepage URL


Email

tishii.ped@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review board of Tokyo Women's Medical University

Address

Kawada-cho 8-1, Shinjuku-ku, Tokyo

Tel

03-3353-8111

Email

rinri.bm@twmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学(東京都)
東京医科歯科大学(東京都)
慶應義塾大学(東京都)
国際医療福祉大学(千葉県)
東京大学医学(東京都)
東邦大学医療センター大森病院(東京都)
静岡県立こども病院(静岡県)
長野県立こども病院(長野県)
三重大学医学部附属病院(三重県)
京都府立医科大学(京都府)
大阪大学(大阪府)
富山大学(富山県)
兵庫県立尼崎医療センター(兵庫県)
北海道大学(北海道大学)
神奈川県立こども医療センター(神奈川県)
福岡市立こども病院(福岡県)
国立成育医療研究センター(東京都)
東京都立小児総合医療センタ―(東京都)
榊原記念病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 10 Month 12 Day

Date of IRB

2021 Year 03 Month 30 Day

Anticipated trial start date

2021 Year 08 Month 24 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational data:
Birth date
Gestational weeks
Birth weight
Gender
Height and weight
Pregnancy
NYHA functional class
Date of PAH diagnosis
Diagnosis of CHD
Cardiac repair
Type of PH
Chromosomal abnormality and underlying syndrome
Six minutes walk distance
QOL
Right heart catheterization data
Echocardiography data
Arterial oxygen saturation
Pulmonary function test data
Electrocardiography data
Blood test and biomarker
Treatment status of PAH


Management information

Registered date

2018 Year 04 Month 24 Day

Last modified on

2021 Year 09 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036915


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name